Previous close | 131.75 |
Open | 132.00 |
Bid | 132.02 x 1200 |
Ask | 132.03 x 900 |
Day's range | 131.08 - 132.42 |
52-week range | 99.14 - 133.10 |
Volume | |
Avg. volume | 8,735,054 |
Market cap | 334.494B |
Beta (5Y monthly) | 0.38 |
PE ratio (TTM) | 943.38 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 3.08 (2.34%) |
Ex-dividend date | 14 Mar 2024 |
1y target est | N/A |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
U.S. stocks were higher on Wednesday, with the Dow leading gains and the S&P 500 setting a closing record, paced drugmaker Merck, while investors looked towards the next piece of inflation data and Federal Reserve commentary for signals on the rate path. Merck & Co advanced 4.96% as the best performer on the Dow after the U.S. Food and Drug Administration approved its therapy for adults suffering from a rare lung condition.